Search - tctmd.com

Displaying 541 - 560 of 989

Sort: Relevancy | Date

Presentation NY Valves 2024

Valve Fracturing During Surgical Valve-in-Valve Procedures

Presenter: Keith B. Allen

June 07, 2024

Presentation NY Valves 2024

The Worst is Yet to Come! A Predictive Model for Failed Aortic Bioprostheses

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

When to Consider the Ross and Mitral Reconstruction?

Presenter: Ismail El-Hamamsy

June 07, 2024

Double Valve Reconstruction – Keys to Success

Presentation NY Valves 2024

Double Valve Surgery– Keys to Success

Presenter: Percy Boateng

June 07, 2024

Presentation NY Valves 2024

Mitral Valve Reconstruction in Connective Tissue Syndromes

Presenter: Ahmed El-Eshmawi

June 07, 2024

Presentation NY Valves 2024

Understanding the Genetics and Classification of Connective Tissue Syndromes

Presenter: Amy Kontorovich

June 07, 2024

Presentation NY Valves 2024

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Helge Möllmann

June 07, 2024

Presentation NY Valves 2024

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

Presenter: Nino Mihatov

June 07, 2024

Presentation NY Valves 2024

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Bassem M. Chehab

June 07, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

Presenter: Sebastian Ludwig

June 07, 2024

Presentation NY Valves 2024

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: John K. Forrest

June 07, 2024

Presentation NY Valves 2024

How to Define and Manage Subclinical Leaflet Thrombosis

Presenter: Hasan Jilaihawi

June 07, 2024

Presentation NY Valves 2024

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

Presenter: Anita W. Asgar

June 07, 2024

Presentation NY Valves 2024

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

Presenter: Pradeep K. Yadav

June 07, 2024

Presentation NY Valves 2024

New Design Features and Changing Clinical Topics for TAVR in the Next Decade!

Presenter: Tamim M. Nazif

June 07, 2024

Presentation NY Valves 2024

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Presenter: Steven J. Yakubov

June 07, 2024

Presentation NY Valves 2024

Arial View of Antithrombotic Therapy Post TAVR

Presenter: Thomas Pilgrim

June 07, 2024

Presentation NY Valves 2024

Extraction of Irretrievable Ruptured Balloon During Balloon Aortic Valvuloplasty Using a Bailout Technique

Presenter: Itsik Ben-Dor

June 07, 2024

Presentation NY Valves 2024

Characteristics, Outcomes, and Management of Patients With Degenerated Trifecta Valves

Presenter: Taha Hatab

June 07, 2024

Advertisement

Valve Fracturing During Surgical Valve-in-Valve Procedures

The Worst is Yet to Come! A Predictive Model for Failed Aortic Bioprostheses

When to Consider the Ross and Mitral Reconstruction?

Double Valve Surgery– Keys to Success

Mitral Valve Reconstruction in Connective Tissue Syndromes

Understanding the Genetics and Classification of Connective Tissue Syndromes

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

The ACURATE Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Case-based Treatment of a Patient With Dyspnea and Increasing Transvalvular Gradients

The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

Transcatheter Edge-to-Edge Repair vs Transcatheter Mitral Valve Replacement in Patients With Primary Mitral Regurgitation and Red Zone Anatomy: A Propensity Score-Matched Analysis

The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities

How to Define and Manage Subclinical Leaflet Thrombosis

Evaluating Mitral TEER in the Management of Moderate Mitral Regurgitation Among Heart Failure Patients

The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities

New Design Features and Changing Clinical Topics for TAVR in the Next Decade!

Impact of Bioprosthetic Valve Performance on 5-year Clinical Outcomes in Patients at Intermediate or Greater Surgical Risk

Arial View of Antithrombotic Therapy Post TAVR

Extraction of Irretrievable Ruptured Balloon During Balloon Aortic Valvuloplasty Using a Bailout Technique

Characteristics, Outcomes, and Management of Patients With Degenerated Trifecta Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content